Back
to sessions
Sep 27
Scientific
MODERATOR(S)
Scott Bratman, MD, PhD - University of Toronto
Eileen Connolly, MD, PhD - New York Presbyterian Hospital Columbia Campus
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
03:00pm - 03:10pm ET
Pirfenidone for Cancer Patients with Grade 2 and Grade 3 Radiation-Induced Lung Injury: Long-Term Efficacy and Exploratory Analysis from a Multicenter, Randomized Phase ll Clinical Trial
Speaker: Biqi Chen, MD - Sun Yat-sen University Cancer Center, Guangzhou -
03:10pm - 03:20pm ET
<sup>64</sup>cu-Anti-CEA M5A PET Imaging Pre and Post Neoadjuvant Radiotherapy In Advanced Rectal Cancer
Speaker: Jeffrey Wong, MD, FASTRO - City of Hope National Medical Center, Duarte -
03:20pm - 03:30pm ET
Clonal Hematopoiesis Following Radiation Therapy as a Novel Predictor of Cancer Control and Survival: Analyses from Prospective Trials
Speaker: Kevin Nead, MD, MPhil - The University of Texas MD Anderson Cancer Center, Houston -
03:30pm - 03:40pm ETSpeaker: Drew Bergman, MD - Memorial Sloan Kettering Cancer Center, New York
-
03:40pm - 03:50pm ET
Phase I Trial with Expansion Cohort of DNA-PK Inhibitor Peposertib and Intensity Modulated Radiation Treatment (IMRT) in Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Speaker: Michael Samuels, MD - University of Miami Miller School of Medicine, Miami -
03:50pm - 04:00pm ET
Radiotherapy Upregulates Membrane TROP-2 via CREB-1 Activation to Potentiate Sacituzumab Govitecan in Triple-Negative Breast Cancer
Speaker: Wen-Chi Yang, MD, PhD - National Taiwan University Hospital, Taipei